US BROKER MOVES: ILMN upgraded at JPMorgan; NKE downgraded at RBC

UPGRADES Western Midstream Partners (WES) Upgraded to Equalweight at Morgan Stanley; PT USD 51 RenaissanceRe (RNR) Upgraded to Buy at Citi; PT USD 345 (prev. USD 335) Pfizer (PFE) Upgraded to Sector Perform at RBC Capital; PT USD 25 Oscar Health (OSCR) Upgraded to Overweight at Barclays; PT USD 35 (prev. USD 30) Illumina (ILMN) Upgraded to Overweight at JPMorgan; PT USD 185 Global-e Online (GLBE) Upgraded to Buy at Truist Securities; PT USD 39 (prev. USD 34) GlobalFoundries (GFS) Upgraded to Buy at Arete; PT USD 95 Entergy (ETR) Upgraded to Outperform at Evercore ISI; PT USD 121 (prev. USD 115) Devon Energy (DVN) Upgraded to Outperform at Evercore ISI; PT USD 54 CAVA Group (CAVA) Upgraded to Buy at UBS; PT USD 90 (prev. USD 85) BorgWarner (BWA) Upgraded to Buy at UBS; PT USD 95 (prev. USD 61) DOWNGRADES Taylor Morrison Home (TMHC) Downgraded to Peerperform at Wolfe Research Nuvation Bio (NUVL) Downgraded to Neutral at UBS; PT USD 124 (prev. USD 138) Nuvation Bio (NUVL) Downgraded to Neutral at Guggenheim Nutrien (NTR) Downgraded to Hold at Berenberg; PT USD 65 (prev. USD 61) Nike (NKE) Downgraded to Sector Perform at RBC Capital; PT USD 50 (prev. USD 70) Hess Midstream (HESM) Downgraded to Underweight at Morgan Stanley; PT USD 38 Bill Holdings (BILL) Downgraded to Hold at Truist Securities INITIATIONS Solid Power (SLDP) Initiated at New Buy at Alliance Global Partners; PT USD 6.75 Power Integrations (POWI) Initiated at New Buy at Needham; PT USD 90 indie Semiconductor (INDI) Initiated at New Hold at TD Cowen Inhibikase Therapeutics (IKT) Initiated at New Outperform at Oppenheimer; PT USD 5 Hyliion Holdings (HYLN) Initiated at New Buy at Needham; PT USD 9 Equity Bancshares (EQBK) Initiated at New Market Perform at Hovde Group CalAmp (CAMP) Initiated at New Buy at Chardan; PT USD 6.50 Barnes & Noble Education (BNED) Initiated at New Outperform at Northland; PT USD 17 Bel Fuse (BELFB) Initiated at New Overweight at JPMorgan; PT USD 370 AnaptysBio (ANAB) Initiated at New Buy at H.C. Wainwright; PT USD 95 ADMA Biologics (ADMA) Initiated at New Outperform at Raymond James; PT USD 21